TREATMENT CHANGES IN PROSTATIC HYPERPLASIA AND CANCER, INCLUDING ANDROGEN DEPRIVATION THERAPY AND RADIOTHERAPY

This publication has 90 references indexed in Scilit:

• Management of radiation failure for localized prostate cancer
  Prostate Cancer and Prostatic Diseases, 1998
• Atypical Small Acinar Proliferation Suspicious for Malignancy in Prostate Needle Biopsies
  The American Journal of Surgical Pathology, 1997
• Chemoprevention of Rat Prostate Carcinogenesis by Use of Finasteride or Casodex
  JNCI Journal of the National Cancer Institute, 1995
• Androgen receptor alterations in prostatic carcinoma
  The Prostate, 1994
• Effect of 5‐α‐reductase inhibition and dexamethasone administration on the growth characteristics and intratumor androgen levels of the human prostate cancer cell line PC‐3
  The Prostate, 1994
• Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs
  Endocrinology, 1993
• Finasteride
  Drugs, 1993
• Pathologic changes associated with androgen deprivation therapy for prostate cancer
  Cancer, 1991
• The clinical development of a 5α-reductase inhibitor, finasteride
  The Journal of Steroid Biochemistry and Molecular Biology, 1990
• Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer
  New England Journal of Medicine, 1984